BRIT J RADIOL 2021 10.1259/bjr.20210352

Long-term follow-up of oxaliplatin-induced liver damage in patients with colorectal cancer

Cha¹, DI; Song, KD; Ha, SY; Hong, JY; Hwang, JA; Ko, SE

ANN SURG 2021 10.1097/SLA.0000000000003268

Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation

Lee¹, S; Kang, TW; Song, KD; Lee, MW; Rhim, H; Lim, HK; Kim, SY; Sinn, DH; Kim, JM; Kim, K; Ha, SY

LIVER INT 2021 10.1111/liv.14798

Clinicopathologic and MRI features of combined hepatocellular-cholangiocarcinoma in patients with or without cirrhosis

Yoon¹, JJ; Hwang, JA; Lee, S; Lee, JE; Ha, SY; Park, YN

INT J HYPERTHER 2021 10.1080/02656736.2021.1876255

Comparison of ablation performance between dual internally cooled wet tip and conventional dual internally cooled tip radiofrequency electrodes: an experimental study in ex vivo bovine liver

Cha¹, DI; Lee, MW; Jeong, WK; Ha, SY; Ahn, SH; Rhim, H; Lim, HK

CANCER RES 2021 10.1158/0008-5472.CAN-20-0568

Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer

Hong¹, SH; Son, KH; Ha, SY; Wee, TI; Choi, SK; Won, JE; Han, HD; Ro, Y; Park, YM; Eun, JW; Nam, SW; Han, JW; Kang, K; You, JS

RADIOLOGY 2020 10.1148/radiol.2020201940

Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma

Min¹, JH; Lee, MW; Park, HS; Lee, DH; Park, HJ; Lim, S; Choi, SY; Lee, J; Lee, JE; Ha, SY; Cha, DI; Carriere, KC; Ahn, JH

J CANCER RES CLIN 2020 10.1007/s00432-020-03437-x

Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma

Ha¹, SY; Yeo, SY; Lee, KW; Kim, SH

EUR RADIOL 2020 10.1007/s00330-020-07438-9

Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis diagnostic performance of CT and MRI

Min¹, JH; Kang, TW; Kim, YY; Cha, DI; Kim, YK; Kim, SH; Sinn, DH; Ha, SY; Kim, K

CANCER GENOMICS PROTEOMICS 2020 10.21873/cgp.20229

Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma

Cho¹, YA; Choi, S; Park, S; Park, CK; Ha, SY

EUR RADIOL 2020 10.1007/s00330-020-07378-4

Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas

Min¹, JH; Kim, SH; Hwang, JA; Hyun, SH; Ha, SY; Choi, SY; Kim, SW; Kim, HS

CANCER RES TREAT 2020 10.4143/crt.2020.208

Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection

Park¹, S; Choi, S; Cho, YA; Sinn, DH; Kim, JM; Park, CK; Ha, SY

CANCERS 2020 10.3390/cancers12092395

Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?

Yoo¹, GS; Il Yu, J; Park, HC; Hyun, D; Jeong, WK; Lim, HY; Choi, MS; Ha, SY

J PATHOL CLIN RES 2020 10.1002/cjp2.179

Digital image analysis in pathologist-selected regions of interest predicts survival more accurately than whole-slide analysis a direct comparison study in 153 gastric carcinomas

Heo¹, YJ; Lee, T; Byeon, SJ; Kim, EJ; Shin, HC; Kim, B; Kang, SY; Ha, SY; Kim, KM

CURR ONCOL 2020 10.3747/co.27.6163

Severe cytomegalovirus gastritis after pembrolizumab in a patient with melanoma

Kim¹, H; Ha, SY; Kim, J; Kang, M; Lee, J

RADIOLOGY 2020 10.1148/radiol.2020192275

Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI A Multicenter Study

Joo¹, I; Kim, SY; Kang, TW; Kim, YK; Park, BJ; Lee, YJ; Choi, JI; Lee, CH; Park, HS; Lee, K; Kim, H; Yu, E; Kang, HJ; Ha, SY; Kim, JY; Ahn, S; Jung, ES; Kim, BH; Han, HS; Lee, JM

PATHOL ONCOL RES 2020 10.1007/s12253-020-00871-7

Clinical Significance of Trk Receptor Expression as a New Therapeutic Target in Hepatocellular Carcinoma

Choi¹, S; Park, S; Cho, YA; Park, CK; Ha, SY

VIRCHOWS ARCH 2020 10.1007/s00428-020-02841-5

Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma

Ha¹, SY; Choi, S; Park, S; Kim, JM; Choi, GS; Joh, JW; Park, CK

IN VIVO 2020 10.21873/invivo.11930

Hepatic Angiosarcoma: Clinicopathologic Study With an Investigation of ROS1 Gene Rearrangements

Jung¹, H; Kim, HN; Jang, Y; Park, CK; Shin, SH; Ha, SY

CANCER RES TREAT 2020 10.4143/crt.2019.261

Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer

Yoo¹, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY

EUR RADIOL 2020 10.1007/s00330-019-06407-1

Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network

Lee¹, JH; Joo, I; Kang, TW; Paik, YH; Sinn, DH; Ha, SY; Kim, K; Choi, C; Lee, GW; Yi, JH; Bang, WC

TRANSL ONCOL 2019 10.1016/j.tranon.2019.07.017

Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study

Kwon¹, D; Kim, B; Shin, HC; Kim, EJ; Ha, SY; Jang, KT; Kim, ST; Lee, J; Kang, WK; Park, JO; Kim, KM

IN VIVO 2019 10.21873/invivo.11736

CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma

Jung¹, H; Kim, HN; Jang, Y; Park, CK; Ha, SY

SCI REP-UK 2019 10.1038/s41598-019-50594-2

Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma

Ha¹, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK

PATHOL RES PRACT 2019 10.1016/j.prp.2019.152434

CCNE1 amplification is associated with liver metastasis in gastric carcinoma

Kim¹, B; Shin, HC; Heo, YJ; Ha, SY; Jang, KT; Kim, ST; Kang, WK; Lee, J; Kim, KM

PATHOLOGY 2019 10.1016/j.pathol.2019.01.013

Gastrointestinal stromal tumour with CDKN2A deletions: a report of three cases

Kim¹, B; Ha, SY; Lee, S; Kim, KM

J MOL DIAGN 2019 10.1016/j.jmoldx.2019.02.007

Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing A Direct Comparison Study with Immunohistochemistry

Choi¹, S; Chu, J; Kim, B; Ha, SY; Kim, ST; Lee, J; Kang, WK; Han, H; Sohn, I; Kim, KM

ANTICANCER RES 2019 10.21873/anticanres.13435

Prognostic Role of Apelin Receptor Expression in Hepatocellular Carcinoma Treated With Curative Surgical Resection

Lee¹, T; Park, CK; Ha, SY

EUR RADIOL 2019 10.1007/s00330-018-5642-5

Pre-operative ADC predicts early recurrence of HCC after curative resection

Lee¹, S; Kim, SH; Hwang, JA; Lee, JE; Ha, SY

PATHOL RES PRACT 2019 10.1016/j.prp.2018.11.013

Pathologic analyses of peritoneal nodules in gastric cancer patients during surgery-A single cancer center experience with diagnostic pitfalls

Bae¹, H; Kim, H; Chu, J; Jang, Y; Koh, HH; Jung, H; Ha, SY; Jang, KT; Kim, KM

PLoS One 2019 10.1371/journal.pone.0210730

Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients

Sinn¹, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

CANCER RES TREAT 2019 10.4143/crt.2018.132

Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients

Lee¹, SH; Lee, B; Shim, JH; Lee, KW; Md, JWY; Kim, SY; Kim, TY; Kim, YH; Ko, YH; Chung, HC; Yu, CS; Lee, J; Rha, SY; Kim, TW; Jung, KH; Im, SA; Moon, HG; Cho, S; Kang, JH; Kim, J; Kim, SK; Ryu, HS; Ha, SY; Il Kim, J; Chung, YJ; Kim, C; Kim, HL; Park, WY; Noh, DY; Park, K

PATHOL RES PRACT 2019 10.1016/j.prp.2018.10.024

The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma

Cho¹, J; Kim, KM; Kim, HC; Lee, WY; Kang, WK; Park, YS; Ha, SY

Abdom Radiol (NY) 2018 10.1007/s00261-018-1653-6

Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors

Cha¹, DI; Kang, TW; Jang, KM; Kim, YK; Kim, SH; Ha, SY; Sohn, I

Abdom Radiol (NY) 2018 10.1007/s00261-018-1480-9

Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance

Min¹, JH; Kim, YK; Sinn, DH; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Kim, MJ

TRANSL ONCOL 2018 10.1016/j.tranon.2018.04.007

Molecular Characterization of Colorectal Signet-Ring Cell Carcinoma Using Whole-Exome and RNA Sequencing

Nam¹, JY; Oh, BY; Hong, HK; Bae, JS; Kim, TW; Ha, SY; Park, D; Lee, WY; Kim, HC; Yun, SH; Park, YA; Joung, JG; Park, WY; Cho, YB

J HEPATOL 2018 10.1016/j.jhep.2018.01.024

Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma

Kim¹, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ

EUR RADIOL 2018 10.1007/s00330-017-5248-3

Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival

Min¹, JH; Kang, TW; Kim, YK; Kim, SH; Shin, KS; Lee, JE; Ha, SY; Sohn, I

J GASTROEN HEPATOL 2018 10.1111/jgh.14035

Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis

Pyo¹, JH; Ha, SY; Hong, SN; Chang, DK; Son, HJ; Kim, KM; Kim, H; Kim, K; Kim, JE; Choi, YH; Kim, YH

PATHOL RES PRACT 2018 10.1016/j.prp.2018.02.007

Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma

Cho¹, J; Ha, SY; Kim, SH; Sung, HH; Kwon, GY

ACTA RADIOL 2018 10.1177/0284185117723040

Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging

Han¹, SB; Kim, YK; Min, JH; Ha, SY; Jeong, WK; Lee, WJ

ANN SURG ONCOL 2018 10.1245/s10434-017-6135-5

Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study

Oh¹, BY; Park, YA; Huh, JW; Yun, SH; Kim, HC; Chun, HK; Kim, SH; Ha, SY; Lee, WY; Cho, YB

HISTOPATHOLOGY 2017 10.1111/his.13292

Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases

Kang¹, G; Kang, Y; Kim, KH; Ha, SY; Kim, JY; Shim, YM; Heinrich, MC; Kim, KM; Corless, CL

J CUTAN PATHOL 2017 10.1111/cup.13006

CD13 is a marker for onychofibroblasts within nail matrix onychodermis: Comparison of its expression patterns in the nail unit and in the hair follicle

Park¹, JH; Lee, DY; Jang, KT; Ha, SY; Kwon, GY; Lee, KH; Shim, JS; Kwon, EJ

EUR J RADIOL 2017 10.1016/j.ejard.2017.036

Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma

Hwang¹, JA; Kang, TW; Kim, YK; Kim, SH; Paik, YH; Ha, SY; Kim, S

PLoS One 2017 10.1371/journal.pone.0185826

Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans

Oh¹, E; Jeong, HM; Kwon, MJ; Ha, SY; Park, HK; Song, JY; Kim, YJ; Choi, JS; Lee, EH; Lee, J; Choi, YL; Shin, YK

SCI REP-UK 2017 10.1038/s41598-017-12469-2

Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area

Yu¹, JI; Choi, C; Ha, SY; Park, CK; Kang, SY; Joh, JW; Paik, SW; Kim, S; Kim, M; Jung, SH; Park, HC

Abdom Radiol (NY) 2017 10.1007/s00261-017-1119-2

Magnetic resonance findings of hepatic epithelioid hemangioendothelioma: emphasis on hepatobiliary phase using Gd-EOB-DTPA

Lee¹, JH; Jeong, WK; Kim, YK; Lee, WJ; Ha, SY; Kim, KW; Kim, J

ONCOTARGET 2017 10.18632/oncotarget.18168

The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs

Kim¹, HK; Ha, SY; Lee, J; Park, SH; Park, JO; Lim, HY; Kang, WK; Park, YS; Kim, ST

ONCOTARGET 2017 10.18632/oncotarget.17941

Twist1 is highly expressed in cancer-associated fibroblasts of esophageal squamous cell carcinoma with a prognostic significance

Yeo¹, SY; Ha, SY; Lee, KW; Cui, Y; Yang, ZT; Xuan, YH; Kim, SH

EUR J RADIOL 2017 10.1016/j.ejrad.2017.04.008

Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum

Min¹, JH; Kim, YK; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Ahn, HS

Abdom Radiol (NY). 2017 May;42(5):1424-1433. doi: 10.1007/s00261-016-1038-7.

Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging

Gu KW1¹, Kim YK2, Min JH1, Ha SY3, Jeong WK1.

Cardiovasc Intervent Radiol. 2017 Mar;40(3):401-409. doi: 10.1007/s00270-016-1525-9. Epub 2016 Dec 8.

Radiofrequency Ablation of Hepatocellular Carcinoma with a "Nodule-in-Nodule" Appearance: Long-Term Follow-up and Clinical Implications

Kang TW1¹, Rhim H2, Song KD1, Lee MW1, Cha DI1, Ha SY3, Ahn JH4.

Mod Pathol. 2017 Jan;30(1):4-14. doi: 10.1038/modpathol.2016.56. Epub 2016 Sep 30.

Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression

Son SM1¹, Ha SY1, Yoo HY2,3, Oh D4, Kim SJ3,5, Kim WS3,5, Ko YH1,3.

Oncotarget. 2017 Jan 10;8(2):2076-2082. doi: 10.18632/oncotarget.10502.

Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma

Joung JG1¹, Ha SY2, Bae JS1, Nam JY1,3, Gwak GY4, Lee HO1,5, Son DS1,6, Park CK2, Park WY1,3,5.

Korean J Radiol. 2017 Jan-Feb;18(1):152-161. doi: 10.3348/kjr.2017.18.1.152. Epub 2017 Jan 5.

Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance

Kang TW1¹, Lee MW1, Song KD1, Kim M1, Kim SS1, Kim SH1, Ha SY2.

Eur J Radiol. 2016 Mar;85(3):680-7. doi: 10.1016/j.ejrad.2015.12.029. Epub 2016 Jan 4.

Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival

Kim M1¹, Kang TW2, Kim YK1, Kim SH1, Kwon W3, Ha SY4, Ji SA5.

J Cancer. 2016 Feb 5;7(5):484-9. doi: 10.7150/jca.13711. eCollection 2016.

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs

Kim ST1¹, Ha SY2, Lee S1, Ahn S2, Lee J1, Park SH1, Park JO1, Lim HY1, Kang WK1, Kim KM2, Park YS1.

Oncotarget. 2016 Feb 16;7(7):7940-51. doi: 10.18632/oncotarget.6958.

The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients

Choi HS1¹,2, Ha SY3, Kim HM1,2, Ahn SM3, Kang MS4,5, Kim KM3, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kang ES2.

Am J Respir Cell Mol Biol. 2016 Feb;54(2):284-96. doi: 10.1165/rcmb.2014-0377OC.

Mitochondrial E3 Ubiquitin Protein Ligase 1 Mediates Cigarette Smoke-Induced Endothelial Cell Death and Dysfunction

Kim SY1¹, Kim HJ2, Park MK2, Huh JW3, Park HY4, Ha SY5, Shin JH2, Lee YS2.

J Pathol. 2016 Nov;240(3):304-314. doi: 10.1002/path.4777.

Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis

Min BH1¹, Hwang J2, Kim NK3, Park G2, Kang SY4, Ahn S4, Ahn S4, Ha SY4, Lee YK4, Kushima R5, Van Vrancken M6, Kim MJ7, Park C2, Park HY2,4, Chae J2, Jang SS2, Kim SJ8, Kim YH1, Kim JI9,10,11, Kim KM12.

Transl Oncol. 2016 Oct;9(5):466-471. doi: 10.1016/j.tranon.2016.08.009.

Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma

Cho J1¹, Lee J1, Kim J1, Kim ST1, Lee S1, Kim SY1, Ha SY2, Park CK3, Lim HY4.

Cancer Res Treat. 2016 Jan;48(1):180-9. doi: 10.4143/crt.2014.321. Epub 2015 Mar 18.

The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy

Ha SY1¹, Choi M1, Lee T1, Park CK1.

Oncotarget. 2016 Jan 26;7(4):4024-35. doi: 10.18632/oncotarget.6602.

Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors

Park C1¹, Ha SY1, Kim ST2, Kim HC3, Heo JS3, Park YS2, Lauwers G4, Lee J2, Kim KM1.

Gut Liver. 2016 Sep 15;10(5):826-35. doi: 10.5009/gnl15543.

NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy

Ha SY1¹, Paik YH2, Yang JW1, Lee MJ1, Bae H1, Park CK1.

Cancer Res Treat. 2016 Jul;48(3):1065-73. doi: 10.4143/crt.2015.302. Epub 2015 Oct 16.

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis

Ha SY1¹, Kim JH2, Yang JW1, Kim J1, Kim B1, Park CK1.

Pathol Res Pract. 2016 Jul;212(7):616-21. doi: 10.1016/j.prp.2016.04.001. Epub 2016 Apr 7.

Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma

Ha SY1¹, Kim JH2, Yang JW3, Bae H4, Cho HY5, Park CK6.

Medicine (Baltimore). 2016 May;95(19):e3534. doi: 10.1097/MD.0000000000003534.

The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution

Kim ST1¹, Ha SY, Lee J, Hong SN, Chang DK, Kim YH, Park YA, Huh JW, Cho YB, Yun SH, Lee WY, Kim HC, Park YS.

Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718.

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods

Kim JM1¹, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.

J Clin Oncol. 2015 Aug 1;33(22):2450-6. doi: 10.1200/JCO.2014.59.9324. Epub 2015 Jun 29.

Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non-Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II Trial

Sun JM1¹, Ahn JS1, Jung SH1, Sun J1, Ha SY1, Han J1, Park K1, Ahn MJ2.

Pathol Res Pract. 2015 Dec;211(12):963-72. doi: 10.1016/j.prp.2015.10.001. Epub 2015 Oct 26.

Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups

Kim Y1¹, Hong M1, Do IG1, Ha SY1, Lee D2, Suh YL3.

Korean J Radiol. 2015 Nov-Dec;16(6):1253-6. doi: 10.3348/kjr.2015.16.6.1253. Epub 2015 Oct 26.

Pancreatic Candidiasis That Mimics a Malignant Pancreatic Cystic Tumor on Magnetic Resonance Imaging: A Case Report in an Immunocompetent Patient

Seong M1¹, Kang TW1, Ha SY2.

Oncotarget. 2015 Nov 10;6(35):38372-80. doi: 10.18632/oncotarget.5368.

Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens

Ahn S1¹,2, Ahn S1,3, Van Vrancken M1, Lee M1, Ha SY1, Lee H4, Min BH4, Lee JH4, Kim JJ4, Choi S5, Jung SH5, Choi MG6, Lee JH6, Sohn TS6, Bae JM6, Kim S6, Kim KM1,3.

Cancer Res Treat. 2015 Oct;47(4):844-52. doi: 10.4143/crt.2014.124. Epub 2015 Feb 13.

Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma

Bang H1¹, Ha SY1, Hwang SH1, Park CK1.

Cancer Res Treat. 2015 Oct;47(4):738-46. doi: 10.4143/crt.2014.224. Epub 2015 Feb 16.

Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopatholoqical Analysis of 72 Cases in a Single Institute

Shin Y1¹, Ha SY1, Hyeon J1, Lee B1, Lee J2, Jang KT1, Kim KM1, Park YS2, Park CK1.

Endocr J. 2015;62(10):857-77. doi: 10.1507/endocrj.EJ15-0234. Epub 2015 Jul 23.

Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis

Yi JW1¹, Park JY, Sung JY, Kwak SH, Yu J, Chang JH, Kim JH, Ha SY, Paik EK, Lee WS, Kim SJ, Lee KE, Kim JH.

Cancer Res Treat. 2015 Oct;47(4):853-61. doi: 10.4143/crt.2014.177. Epub 2015 Feb 16.

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection

Hwang HW1¹, Ha SY1, Bang H1, Park CK1.

Cancer Res Treat. 2015 Jul;47(3):436-40. doi: 10.4143/crt.2013.184. Epub 2014 Nov 17.

Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck

Noh JM1¹, Ha SY2, Ahn YC1, Oh D1, Seol SW1, Oh YL2, Han J2.

Oncotarget. 2015 Jul 30;6(21):18664-73.

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients

Ha SY1¹, Sohn I2, Hwang SH1, Yang JW1, Park CK1.

Diagn Cytopathol. 2015 Jul;43(7):539-44. doi: 10.1002/dc.23242. Epub 2014 Nov 26.

Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations

Song DH1¹, Lee B1, Shin Y1, Choi IH1, Ha SY1, Lee JJ1, Hong ME1, Choi YL1, Han J1, Um SW2.

Genes Chromosomes Cancer. 2015 Jun;54(6):383-96. doi: 10.1002/gcc.22249. Epub 2015 Mar 31.

Integrated Copy Number and Gene Expression Profiling Analysis of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma

Yoon H1¹, Park S, Ju H, Ha SY, Sohn I, Jo J, Do IG, Min S, Kim SJ, Kim WS, Yoo HY, Ko YH.

Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):171-7.

Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma

Ha SY1¹, Song DH, Hwang SH, Cho SY, Park CK.

Ann Dermatol. 2015 Apr;27(2):157-62. doi: 10.5021/ad.2015.27.2.157. Epub 2015 Mar 24.

Identification of Leukocyte-Specific Protein 1-Positive Cells: A Clue to the Cell of Origin and a Marker for the Diagnosis of Dermatofibroma

Jin SY1¹, Choi JS2, Choi YL3, Choi YL3, Kim do H1, Lee SH1.

Int J Cancer. 2015 Apr 1;136(7):1629-35. doi: 10.1002/ijc.29159. Epub 2014 Sep 4.

HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy

Ha SY1¹, Lee J, Jang J, Hong JY, Do IG, Park SH, Park JO, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Kang WK, Kim KM.

J Hepatol. 2015 Mar;62(3):556-62. doi: 10.1016/j.jhep.2014.10.027. Epub 2014 Oct 27.

Microsteatosis may not interact with macrosteatosis in living donor liver transplantation

Han S1¹, Ha SY2, Park CK2, Joh JW3, Kwon CH3, Kwon GY2, Kim G1, Gwak MS1, Jeong WK4, Ko JS5.

Oncotarget. 2015 Mar 10;6(7):5465-74.

Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR

Ha SY1¹, Choi SJ2, Cho JH3, Choi HJ2, Lee J2, Jung K4, Irwin D5, Liu X6,7, Lira ME8, Mao M9, Kim HK3, Choi YS3, Shim YM3, Park WY10, Choi YL1,4,10, Kim J2,3.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3370-3. eCollection 2015.

Nodular smooth muscle metaplasia in multiple peritoneal endometriosis

Kim HS1¹, Yoon G2, Ha SY3, Song SY3.

Oncotarget. 2014 Dec 15;5(23):12260-72.

ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma

Yeo SY1¹, Ha SY2, Yu EJ1, Lee KW1, Kim JH3, Kim SH4.

Virchows Arch. 2014 Jan;464(1):19-27. doi: 10.1007/s00428-013-1504-3. Epub 2013 Nov 19.

Overexpression of matriptase correlates with poor prognosis in esophageal squamous cell carcinoma

Ha SY1¹, Kim KY, Lee NK, Kim MG, Kim SH.